AmyPore Investors
AmyPore develops an innovative drug that targets a common mechanism of Alzheimer's and Parkinson's diseases.
Headquarters:
Septèmes-les-vallons, Provence-Alpes-Cote d'Azur, France
Employee Number:
1-10
Technology:
NeuroTech
Industry:
Neuro Medicine (Tech and Pharma)
Investor Type:
Healthcare Company
Founded Date:
2018